FDA Drug Application (203126) for NIFEDIPINE by TWI PHARMS INC

Back to FDA Applications sponsored by TWI PHARMS INC

Application Number203126
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB2 Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNIFEDIPINE
Active IngredientNIFEDIPINE



Back to FDA Applications sponsored by TWI PHARMS INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.